US2013317466A1PendingUtilityA1

External Catheter with Antiseptic Agent

Assignee: ADAPTA MEDICAL INCPriority: Sep 25, 2006Filed: Jul 23, 2013Published: Nov 28, 2013
Est. expirySep 25, 2026(~0.2 yrs left)· nominal 20-yr term from priority
A61F 5/453
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An external catheter device is disclosed which prevents infection arising from bacterial and/or yeast growth within the external catheter. To achieve such result, the external catheter device is coated with an antiseptic agent that is able to effectively kill and prevent the growth of bacteria and yeast. Additionally, the external catheter device may have an adhesive agent coating on its inner surface to prevent the condom from shifting while on the patient's penis.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An external catheterization device, the device comprising:
 an ensheathing condom;   wherein the ensheathing condom contains an antiseptic agent on its interior surface.   
     
     
         2 . The device of  claim 1 , wherein the antiseptic agent contains an anti-bacterial and/or anti-yeast compound. 
     
     
         3 . The device of  claim 2 , wherein the anti-bacterial compound is composed of nitrofurazone, chlorhexadine, silver sulfadiazine, minocycline, rifampin, or any combination thereof. 
     
     
         4 . The device of  claim 2 , wherein the anti-yeast compound is composed of nystatin, fluconazole, miconazole, troconazole, ibutoconazole, or any combination thereof. 
     
     
         5 . The device of  claim 1 , wherein the ensheathing condom fits tightly around the shaft and head of the penis. 
     
     
         6 . The device of  claim 1 , wherein the ensheathing condom is further comprised of an end surrounding a head of the penis and a reservoir tip for urine collection. 
     
     
         7 . The device of  claim 1 , wherein the ensheathing condom further includes an adhesive compound on its inner surface to keep the ensheathing condom in place. 
     
     
         8 . The device of  claim 1 , further including a connection port for directing urine out of the ensheathing condom. 
     
     
         9 . An external catheterization device, the device comprising:
 an ensheathing condom having a body, an end surrounding the head of the penis, and a reservoir tip;   wherein the ensheathing condom has on its inner surface an antiseptic agent.   
     
     
         10 . The device of  claim 9 , wherein the antiseptic agent is composed of an anti-bacterial and/or anti-yeast compound. 
     
     
         11 . The device of  claim 10 , wherein the anti-bacterial compound is composed of nitrofurazone, chlorhexadine, silver sulfadiazine, minocycline, rifampin, or any combination thereof. 
     
     
         12 . The device of  claim 10 , wherein the anti-yeast compound is composed of nystatin, fluconazole, miconazole, troconazole, ibutoconazole, or any combination thereof 
     
     
         13 . The device of  claim 9 , further including an adhesive agent on the inner surfaces of the body and the end. 
     
     
         14 . The device of  claim 9 , further including an adhesive agent on the inner surface of the body only. 
     
     
         15 . The device of  claim 9 , further including a connection port for directing urine out of the ensheathing condom. 
     
     
         16 . An external catheterization device, the device comprising:
 an ensheathing condom having a body which extends over a shaft of a penis, an end surrounding a head of the penis, and a reservoir tip;   a tube connecting end; and   a tube connection port;   wherein the body, the end, and the reservoir have on their inner surfaces an antiseptic agent coating; and   wherein the tube connection port is used to empty urine from within the reservoir and the ensheathing condom.   
     
     
         17 . The device of  claim 16 , wherein the antiseptic agent coating is composed of anti-bacterial and/or anti-yeast compound. 
     
     
         18 . The device of  claim 16 , wherein the anti-bacterial compound is composed of nitrofurazone, chlorhexadine, silver sulfadiazine, minocycline, rifampin, or any combination thereof. 
     
     
         19 . The device of  claim 16 , wherein the anti-yeast compound is composed of nystatin, fluconazole, miconazole, troconazole, ibutoconazole, or any combination thereof. 
     
     
         20 . The device of  claim 16 , further including an adhesive agent on the inner surfaces of the body and the end.

Join the waitlist — get patent alerts

Track US2013317466A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.